Skip to main content
Erschienen in: Wiener klinische Wochenschrift 9-10/2013

01.05.2013 | original article

Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and crohn’s disease


verfasst von: Assoc. Prof. Murat Kekilli, MD, Yavuz Beyazit, MD, Adnan Tas, MD, Bilge Tunc, MD, Abdurrahim Sayilir, MD, Aysel Ulker, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2013

Einloggen, um Zugang zu erhalten

Summary

Aim

The aim of this study was to demonstrate that the presence of atypical perinuclear antineutrophil cytoplasmic antibodies (pANCA) in indeterminate colitis (IC) patients and the potential role of pANCA for predicting the patients either with ulcerative colitis (UC) or Crohn’s disease (CD) for UC and CD.

Material and methods

Outpatients and inpatients from the hospital were retrospectively enrolled between April 2008 and December 2010. A total of 25 IC patients enrolled in the present study. Subsequently, 25 randomly selected serum samples were tested for pANCA in our laboratory. Determination of pANCA was performed by enzyme linked immunosorbent assay.

Results

Minimum follow-up was 12 months. The mean duration of disease was 20.52 months. The diagnosis was changed to UC in 13, to CD in 5 patients. The remaining 7 patients are still classified with IC, with mean disease duration of 21.29 months. Duration of disease differs statistically when comparing pANCA positive versus pANCA negative. A positive correlation was found between IC and disease location in our study.

Conclusion

Patients with an initial diagnosis of IC who have positive serology are given a definitive diagnosis of UC or CD, respectively, more often than patients with negative serology.
Literatur
1.
Zurück zum Zitat Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242–7.PubMedCrossRef Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242–7.PubMedCrossRef
2.
3.
Zurück zum Zitat Meucci G, Bortoli A, Riccioli FA, et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multicenter study in northern Italy. Eur J Gastroenterol Hepatol. 1999;11:909–13.PubMedCrossRef Meucci G, Bortoli A, Riccioli FA, et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multicenter study in northern Italy. Eur J Gastroenterol Hepatol. 1999;11:909–13.PubMedCrossRef
4.
Zurück zum Zitat Scott P. Do serological markers and cytokines determine the indeterminate? J Clin Gastroenterol. 2004;38:51–6.CrossRef Scott P. Do serological markers and cytokines determine the indeterminate? J Clin Gastroenterol. 2004;38:51–6.CrossRef
5.
Zurück zum Zitat Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn’s Colitis. 2012 Dec;6(10):965–90.CrossRef Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn’s Colitis. 2012 Dec;6(10):965–90.CrossRef
6.
Zurück zum Zitat Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohn’s Colitis. 2010;4:28–62.CrossRef Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohn’s Colitis. 2010;4:28–62.CrossRef
7.
Zurück zum Zitat Dejaco C, Osterreicher C, Angelberger S, et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy. 2003;35:1004–8.PubMedCrossRef Dejaco C, Osterreicher C, Angelberger S, et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy. 2003;35:1004–8.PubMedCrossRef
8.
Zurück zum Zitat Pera A, Bellando P, Caldera D, et al. Colonoscopy in IBD: diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987;92:181–5.PubMed Pera A, Bellando P, Caldera D, et al. Colonoscopy in IBD: diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987;92:181–5.PubMed
9.
Zurück zum Zitat Morson BC. Colitis unclassified. In: Morson BC, Dawson IMP, editors. Gastrointestinal Pathology. Oxford: Blackwell; 1974:485–6. Morson BC. Colitis unclassified. In: Morson BC, Dawson IMP, editors. Gastrointestinal Pathology. Oxford: Blackwell; 1974:485–6.
10.
Zurück zum Zitat Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–1993. A prospective population-based study. Scand J Gastroenterol. 1996;31:362–6.PubMedCrossRef Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–1993. A prospective population-based study. Scand J Gastroenterol. 1996;31:362–6.PubMedCrossRef
11.
Zurück zum Zitat Hildebrand H, Frederickson B, Homlquist L, et al. Chronic inflammatory bowel disease in children and adolescent in Sweden. J Pediatr Gastroentrol Nutr. 1991;13:293–7.CrossRef Hildebrand H, Frederickson B, Homlquist L, et al. Chronic inflammatory bowel disease in children and adolescent in Sweden. J Pediatr Gastroentrol Nutr. 1991;13:293–7.CrossRef
12.
Zurück zum Zitat Stewenius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol. 1995;30:38–43.PubMedCrossRef Stewenius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol. 1995;30:38–43.PubMedCrossRef
13.
Zurück zum Zitat Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788–91.PubMedCrossRef Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788–91.PubMedCrossRef
14.
Zurück zum Zitat Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730–4.PubMedCrossRef Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730–4.PubMedCrossRef
15.
Zurück zum Zitat Vasiliauskas EA, Pleavy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup. Gastroenterology. 1996;110:1810–19.PubMedCrossRef Vasiliauskas EA, Pleavy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup. Gastroenterology. 1996;110:1810–19.PubMedCrossRef
16.
Zurück zum Zitat Ekbom A. Indeterminate IBD: the magnitude of the problem. Inflamm Bowel Dis. 2000;6(Suppl 1):14–15. Ekbom A. Indeterminate IBD: the magnitude of the problem. Inflamm Bowel Dis. 2000;6(Suppl 1):14–15.
Metadaten
Titel
Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and crohn’s disease

verfasst von
Assoc. Prof. Murat Kekilli, MD
Yavuz Beyazit, MD
Adnan Tas, MD
Bilge Tunc, MD
Abdurrahim Sayilir, MD
Aysel Ulker, MD
Publikationsdatum
01.05.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 9-10/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0363-x

Weitere Artikel der Ausgabe 9-10/2013

Wiener klinische Wochenschrift 9-10/2013 Zur Ausgabe

gesellschaft der ärzte in wien

Veranstaltungen